Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8835597 | Journal of Surgical Research | 2018 | 7 Pages |
Abstract
Etanercept can be a promising agent in mesenteric ischemic reperfusion injury as it does not only inhibit inflammation by blocking tumor necrosis factor-α in circulation but also restores vascular contractility during reflow. These findings support an unexplained recuperative effect of drug beyond its anti-inflammatory effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
S. Erpulat MD, Tamila PhD, Sahika PhD, Sibel S. MD, Arzu MD,